Skip to main content

CONTRAFECT Corp

CFRXDelisted Dec 27, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001478069

CONTRAFECT Corp was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Feb 16, 2023; 40 institutions reported holding it in 13F filings for Q4 2022, worth $1.08M in total; no superinvestor held it.

Key figures

Market cap
–
Not available
Insider buys
0
Open market, last 90 days
Insider sells
0
Open market, last 90 days
13F holders
40
Q4 2022, −6 vs. previous quarter
13F value
$1.08M
Reported value at the end of Q4 2022
Superinvestors holding
0
At the end of Q4 2022

From SEC filings, in USD.

Revenue, FY2022
–
No comparable prior period
Net income, FY2022
-$65.2M
No comparable prior period
Free cash flow, FY2022
-$46.0M
No comparable prior period
Revenue, Q3 FY2023
–
No comparable prior period

Superinvestors holding CFRX, Q4 2022

Go to the superinvestors tab

No superinvestor reported holding CFRX at the end of Q4 2022.

Latest insider trades

See all insider trades

Open-market purchases and sales by CONTRAFECT Corp insiders from Form 4, newest first.

No open-market purchases or sales by CONTRAFECT Corp insiders are on file.

Top 10 13F holders, Q4 2022

See all 40 holders

The largest institutional positions in CONTRAFECT Corp at the end of Q4 2022; share changes are against Q3 2022.

Institutions holding CFRX in Q4 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Armistice Capital, LLC4,095,150$393.1K0.01%+4,095,150New
Acadian Asset Management LLC1,588,806$151.0K0.00%00.0%Unchanged
Artal Group S.A.1,500,000$144.0K0.01%00.0%Unchanged
Fosun International Ltd745,385$74.5K0.01%00.0%Unchanged
BlackRock Inc.519,432$49.9K0.00%+1,606+0.3%Added
Renaissance Technologies LLC477,900$46.0K0.00%+351,200+277.2%Added
Vanguard Group Inc423,968$40.7K0.00%−205,531−32.6%Reduced
Geode Capital Management, LLC329,729$31.0K0.00%−756−0.2%Reduced
Virtu Financial LLC271,242$26.0K0.00%+89,069+48.9%Added
Two Sigma Investments, LP187,551$18.0K0.00%−45,100−19.4%Reduced

Holders of 5% or more of CFRX

See all 1 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of CONTRAFECT Corp.

Largest holders of CFRX from 13D and 13G filings
HolderLatest formStakeChangeFirst filedLatest filingFiling
Armistice Capital, LLC13G9.99%1.19M shares–Feb 14, 20233 filingsAug 14, 2025SEC